Total Equity - Fusion Antibodies PLC (LSE:FAB) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 3.4 GBX

Updated:

Fusion Antibodies PLC
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Fusion Antibodies PLC
Total Equity Peer Comparison

ONT

O

ORPH

DXRX

ERGO

HVO

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Fusion Antibodies PLC LSE:FAB	Total Equity £1.5m	CAGR 3-Years -42%	CAGR 5-Years -24%	CAGR 10-Years N/A
	Oxford Nanopore Technologies PLC LSE:ONT	Total Equity £643.9m	CAGR 3-Years 51%	CAGR 5-Years 35%	CAGR 10-Years N/A
O	Open Orphan PLC LSE:ORPH	Total Equity £20.2m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Diaceutics PLC LSE:DXRX	Total Equity £42.5m	CAGR 3-Years 28%	CAGR 5-Years 87%	CAGR 10-Years N/A
	Ergomed PLC LSE:ERGO	Total Equity £90.9m	CAGR 3-Years 28%	CAGR 5-Years 22%	CAGR 10-Years N/A
	hVIVO PLC LSE:HVO	Total Equity £34.3m	CAGR 3-Years 15%	CAGR 5-Years 54%	CAGR 10-Years 47%

See Also

Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Total Equity amounts to 1.5m GBP.

Over the last year, the Total Equity growth was -43%. The average annual Total Equity growth rates for Fusion Antibodies PLC have been -42% over the past three years , -24% over the past five years .

Join more than 137,200+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.